Earnings release
Page 1
ASX ANNOUNCEMENT 18 February 2026 Biome Half Year Results and Webinar ● Biome to release Appendix 4D and Half Yearly Report for the period ended 31 December 2025 on Monday 23 February 2026 ● Company to host investor webinar on Wednesday 25 February 2026 at 9:30am (AEDT) ● Blair Vega Norfolk, Managing Director and Founder, will present an overview of the results and business update ● Q&A session to follow the presentation Microbiome health company Biome Australia Limited (ASX: BIO) (‘Biome’ or ‘the company’) advises that its Appendix 4D and Half Yearly Report for the half year ended 31 December 2025 will be released to the market on Monday 23 February 2026. The release will include Biome’s interim financial results, key business highlights and an update on the company’s progress against its Vision 27 strategic plan. Investor Webinar Following the release of the half year results, Biome will host a live investor webinar on Wednesday 25 February 2026 at 9:30am (AEDT). The webinar will be presented by Managing Director and Founder, Blair Vega Norfolk, and will include an overview of the H1 FY26 financial results, business highlights and progress across key strategic initiatives. Investors and stakeholders will have the opportunity to ask questions during a live Q&A session following the presentation. You may email questions in advance to corporate@biomeaustralia.com. Webinar Details Date: Wednesday 26 February 2026 Time: 9:30am (AEDT) Presenter: Blair Vega Norfolk, Managing Director and Founder Registration link Investors are encouraged to register in advance to secure their place.
Page 2
For the latest company updates, announcements and to sign up for future investor communications, please visit the Biome Investor Hub: https://investorhub.biomeaustralia.com/ –ENDS– This announcement has been authorised for release by the Board of Biome Australia Limited. About Biome Australia Limited Biome Australia develops, licenses, commercialises and markets innovative, evidence-based live biotherapeutics (probiotics) and complementary medicines supported by clinical research. Biome aims to improve health outcomes and quality of life, making products accessible through professional health channels. Incorporated in Australia in 2018, Biome distributes locally and internationally. In partnership with leading microbiome research organisations, Biome produces unique live biotherapeutic products with innovative delivery technologies improving stability and efficacy for its flagship Activated Probiotics ® range. Supported by randomised double-blind placebo-controlled clinical trials, Activated Probiotics ® and Activated Therapeutics ® help prevent and support management of various health concerns including low mood and sleep, bone health, iron malabsorption, mild eczema and IBS. Through practitioner-recommended distribution, Biome educates health professionals on gut microbiota’s systemic health effects, providing evidence-based natural medicines for prevalent chronic health concerns. For more information visit: www.biomeaustralia.com Investor Relations Lauren Dwyer - CFO corporate@biomeaustralia.com Media enquiries media@activated.co Forward Looking Statements This release may contain forward looking statements, including but not limited to projections, guidance on future revenues, earnings, other potential synergies and estimates and the future performance of Biome (Forward Looking Statements). Forward Looking Statements are provided as a general guide only and should not be relied upon as an indication or guarantee of future performance. Actual results, performance or achievements may differ materially from those expressed or implied in such Forward Looking Statements
Page 3
and any projections and assumptions on which these Forward Looking Statements are based. Such statements may assume the success of Biome’s business strategies. You are cautioned not to place undue reliance on Forward Looking Statements. The Forward Looking Statements are based on information available to Biome as at the date of this release. Nothing in this release is a promise or representation as to the future. No representation or warranty, express or implied, is made as to the accuracy, likelihood of achievement or reasonableness of any Forward Looking Statements contained in this release. Except as required by law or regulation (including the ASX Listing Rules), Biome does not undertake to provide any additional or updated information whether as a result of a change in expectations or assumptions, new information, future events or results or otherwise. To the maximum extent permitted by law, Biome excludes and expressly disclaims all liabilities in respect of, and makes no representation or warranty, express or implied as to the fairness, currency, accuracy, reliability or completeness of information in this release or the accuracy, likelihood of achievement or reasonableness of any Forward Looking Statements contained in, implied by, the information in this release or any part of it, or that this release contains all material information about Biome or which a prospective investor or purchaser may require in evaluating a possible investment in Biome or acquisition of securities in Biome.